Product
LY2835219
Aliases
abemaciclib, Abemaciclib
Name
Verzenio
FDA Approved
Yes
2 clinical trials
1 organization
2 indications
1 document
Indication
Breast NeoplasmsIndication
Advanced CancerClinical trial
A Phase 1b Study of Abemaciclib in Combination With Therapies for Patients With Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-15
Clinical trial
A Phase 1 Study of a CDK 4/6 Dual Inhibitor in Participants With Advanced CancerStatus: Completed, Estimated PCD: 2014-05-29
Document
DailyMed Label: VerzenioOrganization
Eli Lilly and Company